Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The apicoplast DNA polymerase (apPOL) is an essential enzyme in Plasmodium parasites, responsible for the replication and repair of the 35 kb circular genome within the apicoplast, a non-photosynthetic plastid organelle [1, 4]. As the sole DNA polymerase localized to this organelle, apPOL is a multitasking enzyme that performs both high-fidelity replicative synthesis and lesion bypass synthesis [12, 16]. It belongs to the A-family of DNA polymerases but is evolutionarily distinct from human polymerases, sharing closer homology with bacterial and cyanobacterial enzymes [1, 5]. Because the apicoplast is vital for the biosynthesis of essential metabolites like isoprenoids, heme, and fatty acids, inhibition of apPOL leads to the loss of the organelle and eventual parasite death [1, 11]. This process is often characterized by a "delayed death" phenotype, where the parasite survives one division cycle before succumbing [1, 2]. The lack of a direct human ortholog makes apPOL a highly attractive target for the development of novel antimalarial drugs, with small molecules like MMV666123 identified as potent and selective inhibitors [3, 9]. Structural studies using cryo-electron microscopy have revealed unique conformational changes and potential allosteric sites that could be exploited for drug design [4, 20].
Inhibition of apicoplast DNA replication and repair, leading to the loss of the apicoplast organelle and subsequent parasite death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apicoplast DNA polymerase (apPOL).